Edap Tms S.A. (NASDAQ:EDAP) Expected to Post Quarterly Sales of $12.96 Million

Wall Street brokerages expect Edap Tms S.A. (NASDAQ:EDAPGet Rating) to report sales of $12.96 million for the current quarter, according to Zacks. Two analysts have made estimates for Edap Tms’ earnings, with estimates ranging from $12.20 million to $13.72 million. Edap Tms posted sales of $12.35 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 4.9%. The firm is scheduled to issue its next quarterly earnings report after the market closes on Monday, January 1st.

According to Zacks, analysts expect that Edap Tms will report full year sales of $61.23 million for the current year, with estimates ranging from $60.12 million to $62.34 million. For the next year, analysts forecast that the firm will report sales of $74.25 million, with estimates ranging from $72.65 million to $75.84 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Edap Tms.

Edap Tms (NASDAQ:EDAPGet Rating) last issued its quarterly earnings results on Wednesday, March 30th. The medical equipment provider reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.03. Edap Tms had a net margin of 1.51% and a return on equity of 1.53%. During the same quarter in the prior year, the firm posted $0.03 earnings per share.

Several brokerages recently issued reports on EDAP. StockNews.com began coverage on shares of Edap Tms in a research note on Thursday, March 31st. They set a “hold” rating on the stock. Zacks Investment Research upgraded Edap Tms from a “sell” rating to a “hold” rating in a report on Tuesday, May 3rd.

Shares of NASDAQ EDAP opened at $6.49 on Monday. Edap Tms has a 52-week low of $5.00 and a 52-week high of $7.88. The company has a debt-to-equity ratio of 0.11, a quick ratio of 3.34 and a current ratio of 3.75. The firm has a 50 day moving average price of $7.10 and a two-hundred day moving average price of $6.59. The stock has a market cap of $217.19 million, a P/E ratio of 649.65 and a beta of 1.34.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Soleus Capital Management L.P. lifted its position in Edap Tms by 6.5% during the 4th quarter. Soleus Capital Management L.P. now owns 3,148,609 shares of the medical equipment provider’s stock worth $18,860,000 after acquiring an additional 192,242 shares during the period. Morgan Stanley increased its position in Edap Tms by 92.2% during the third quarter. Morgan Stanley now owns 1,497,285 shares of the medical equipment provider’s stock worth $9,553,000 after buying an additional 718,460 shares in the last quarter. Fosun International Ltd increased its position in Edap Tms by 1.7% during the fourth quarter. Fosun International Ltd now owns 179,039 shares of the medical equipment provider’s stock worth $949,000 after buying an additional 3,000 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new position in Edap Tms during the first quarter worth $723,000. Finally, Bank of America Corp DE grew its position in shares of Edap Tms by 403.4% in the second quarter. Bank of America Corp DE now owns 42,959 shares of the medical equipment provider’s stock valued at $304,000 after purchasing an additional 34,426 shares during the period. Institutional investors and hedge funds own 28.71% of the company’s stock.

Edap Tms Company Profile (Get Rating)

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution.

Featured Stories

Get a free copy of the Zacks research report on Edap Tms (EDAP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Edap Tms (NASDAQ:EDAP)

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.